Results from the company’s Phase I trial found its prodrug, SPT-300, was well tolerated, opening the doors to a Phase IIb ...

DHA Omega-3 Supplements from Canola Health Canada has Approved Nutriterra DHA Canola as an ingredient in dietary supplements ...

Goldman Sachs analyst Rajan Sharma maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £16.90.

TD Cowen analyst Steve Scala maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of $45.00. The ...

Teva Pharmaceutical Industries Ltd. ADR 0.84% $19.88B ...